¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"thin layer rapid use epicutaneous test2"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
non-rapid eye movement
ºñ±Þ¼Ó¾È±¸¿îµ¿
rapid alternative movement
ºü¸¥±³´ë¿îµ¿
rapid detection method
½Å¼Ó°ËÃâ¹ý
rapid eye movement
ºü¸¥´«¿îµ¿, ±Þ¼Ó¾È±¸¿îµ¿
rapid filtration
±Þ¼Ó¿©°ú, ±Þ¼Ó°Å¸£±â
rapid grower
ºü¸¥¹ßÀ°±Õ, ½Å¼Ó¹ßÀ°±Õ
rapid induction
±Þ¼Ó¸¶ÃëÀ¯µµ
rapid-sequence induction
ºü¸¥¿¬¼Ó¸¶ÃëÀ¯µµ
rapid-sequence intubation
ºü¸¥¿¬¼Ó±â°ü»ð°ü
basal layer
¹Ù´ÚÃþ, ±âÀúÃþ
buffy layer
¿¬Ãþ
circular layer
µ¹¸²Ãþ
clear layer
Åõ¸íÃþ
compact layer
Ä¡¹ÐÃþ
cone cell layer
¿ø»Ô¼¼Æ÷Ãþ, ¿øÃß¼¼Æ÷Ãþ
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
11
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
rapid eye movements movement
ºü¸¥´«¿îµ¿, ±Þ¼Ó´«¿îµ¿
thin basement membrane disease
¾ãÀº¹Ù´Ú¸·º´, ¾ãÀº±âÀú¸·º´
thin glomerular basement disease
¾ãÀºÅ丮¹Ù´Ú¸·º´, ¾ãÀº»ç±¸Ã¼±âÀú¸·º´
layer
Ãþ
basal layer
¹Ù´ÚÃþ
papillary layer
À¯µÎÃþ
plexiform layer
¾ó±âÃþ
reticular layer
±×¹°Ãþ
spinous layer
°¡½ÃÃþ
spongy layer
ÇØ¸éÃþ
submucous layer
Á¡¸·¹ØÃþ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
thin-layer chromatography
¹ÚÃþÅ©·Î¸¶Åä±×·¡ÇÇ
thin section
¾ãÀºÀýÆí, ¼¼ÀýÆí
rapid filtration
±Þ¼Ó°Å¸£±â
rapid grower
ºü¸¥¹ßÀ°±Õ, ½Å¼Ó¹ßÀ°±Õ
rapid induction
±Þ¼Ó¸¶ÃëÀ¯µµ
rapid-sequence induction
ºü¸¥¿¬¼Ó¸¶ÃëÀ¯µµ
rapid-sequence intubation
ºü¸¥¿¬¼Ó±â°ü»ð°ü
non-rapid eye movement
ºñ±Þ¼Ó¾È±¸¿îµ¿
rapid alternative movement
ºü¸¥¾ù°¥¸²¿îµ¿
rapid detection method
½Å¼Ó°ËÃâ¹ý
rapid eye movement
ºü¸¥´«¿îµ¿, ±Þ¼Ó´«¿îµ¿
rapid ventricular filling stage
ºü¸¥½É½ÇÃæ¸¸±â
agar layer method
¿ì¹«ÁßÃþ¹ý
basal layer
¹Ù´ÚÃþ
buffy layer
¿¬Ãþ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
MOTSA (multiple overlapping thin-slab acquisition)
´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
hallucinogen use disorder
ȯ°¢Á¦»ç¿ëÀå¾Ö(º´)(ü³ÊÆð¥ÞÅéÄî¡äô)
harmful use
À¯ÇØ<ÇØ·Î¿î>»ç¿ë(êóúªÞÅéÄ)
phencyclidine use disorder
Ææ½ÎÀÌŬ¸®µò »ç¿ëÀå¾Ö(º´)
piriform neuron layer [purkinjes layer]
Á¶·Õ¹ÚÃþ
MP-RAGE (magnetization prepared rapid acquisition gr
ÀÚÈ Áغñ °í¼Ó °æ»ç¿¡ÄÚ È¹µæ
REM, see Rapid Eye Movement
·½, ±Þ¼Ó¾È±¸¿îµ¿
RPR test => rapid plasma reagin test
½Å¼ÓÇ÷À帮¾ÆÁø<°¨ÀÛÇ×ü>½ÃÇè
grower, rapid
½Å¼Ó¹ßÀ°±Õ
phase of rapid filling
±Þ¼ÓÃæ¸¸±â(ÐááÜ õöØ»Ðï).
rapid acquisition with relaxation enhancement (RARE)
±Þ¼Ó ȹµæ ÀÌ¿Ï Áõ°
rapid alternative movement
ºü¸¥ ¾ù°¥¸²¿îµ¿, ±Þ¼Ó±³´ë(ÎßÓÛ)¿îµ¿
rapid cure adhesive
¼Ó°ÇÁ¢ÂøÁ¦(áÜËë ïÈó·ð¥).
rapid cycling
±Þ¼Ó¼øÈ¯¼º(ÐááÜâàü»àõ)
rapid decompression
±Þ°Ý°¨¾Ð(ÐáÌÊõäâ).
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
thin-layer chromatography
¹ÚÃþ(ÚÝöµ)Å©·Î¸¶Åä±×·¡ÇÇ
clinical use
ÀÓ»óÀû(ÀÎ) ÀÌ¿ë
excessive use
°ú¿ë(ΦéÄ).
external use
¿Ü¿ë(èâéÄ).
hallucinogen use disorder
ȯ°¢Á¦»ç¿ëÀå¾Ö(º´)(ü³ÊÆð¥ÞÅéÄî¡äô)
harmful use
À¯ÇØ<ÇØ·Î¿î>»ç¿ë(êóúªÞÅéÄ)
internal use
³»¿ë(Ò®éÄ).
multiple overlapping thin slab acquisition (MOTSA)
´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
opioid use disorder
¾ÆÆí¾çÁ¦Á¦ »ç¿ëÀå¾Ö(º´).
phencyclidine use disorder
Ææ½ÎÀÌŬ¸®µò »ç¿ëÀå¾Ö(º´)
thin filament
¼¼»ç(á¬Þê)
thin film
¹ÚÃþµµ¸»Ç¥º»(ÚÝöµÓóØÆøöÜâ)
thin pannus =p. tenuis
¿°¼º(æúàõ)ÆÇ´©½º
thin section
¾ãÀº ÀýÆí, ¼¼ÀýÆí
thin segment
¼¼ºÎ(á¬Ý»), ¹ÚºÎ(ÚÝÝ»).
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½